Introduction
Methods
Data source and claims
Study period
Identification of study cohorts
Cost analyses and resource utilization
Statistical methods
Results
Study cohorts
Baseline demographics and clinical characteristics
Parameter | All Patients (n = 29,863) | Patients with Diabetes* (n = 5,501) | Patients without Diabetes* (n = 24,362) | P-value‡ |
---|---|---|---|---|
Age, mean (SD), years | 55.54 (12.05) | 57.83 (11.00) | 55.03 (12.22) | < 0.0001 |
Female, n (%) | 11,097 (37.2) | 2,316 (42.1) | 8,781 (36.0) | < 0.0001 |
Follow-up, mean (SD), days | 694 (348) | 687 (353) | 695 (347) | 0.12 |
Plan type, n (%) | < 0.0001 | |||
HMO | 12,167 (40.7) | 2,444 (44.4) | 9,723 (39.9) | |
PPO | 11,356 (38.0) | 1,941 (35.3) | 9,415 (38.6) | |
Unknown | 306 (1.0) | 48 (0.9) | 258 (1.1) | |
Plan payer type, n (%) | < 0.0001 | |||
Commercial | 22,270 (74.6) | 3,841 (69.8) | 18,429 (75.6) | |
Medicare risk | 4,199 (14.1) | 974 (17.7) | 3,225 (13.2) | |
Unknown | 1,587 (5.3) | 222 (4.0) | 1,365 (5.6) | |
CCI, mean (SD) | 0.56 (1.12) | 1.61 (1.22) | 0.32 (0.94) | < 0.0001 |
Pre-index comorbidities, n (%) | ||||
Hypertension | 11,648 (39.0) | 3,408 (62.0) | 8,240 (33.8) | < 0.0001 |
Dyslipidemia | 8,976 (30.1) | 2,642 (48.0) | 6,334 (26.0) | < 0.0001 |
Diabetes | 5,501 (18.4) | 5,501 (100.0) | 0 (0.0) | - |
Pre-index medications, n (%) | ||||
Statins | 4,749 (15.9) | 1,708 (31.0) | 3,041 (12.5) | < 0.0001 |
ACE inhibitors | 4,027 (13.5) | 1,805 (32.8) | 2,222 (9.1) | < 0.0001 |
ARBs | 1,316 (4.4) | 473 (8.6) | 843 (3.5) | < 0.0001 |
β-blockers | 4,045 (13.5) | 1,086 (19.7) | 2,959 (12.1) | < 0.0001 |
Calcium channel blockers | 3,070 (10.3) | 970 (17.6) | 2,100 (8.6) | < 0.0001 |
Diuretics | 2,919 (9.8) | 849 (15.4) | 2,070 (8.5) | < 0.0001 |
Index CV event type† | ||||
CABG | 1,904 (6.4) | 412 (7.5) | 1,492 (6.1) | 0.0002 |
Other CV procedure | 8,613 (28.8) | 1,417 (25.8) | 7,196 (29.5) | < 0.0001 |
Myocardial infarction | 9,231 (30.9) | 1,420 (25.8) | 7,811 (32.1) | < 0.0001 |
Heart failure | 2,244 (7.5) | 686 (12.5) | 1,558 (6.4) | < 0.0001 |
Angina | 1,651 (5.5) | 315 (5.7) | 1,336 (5.5) | 0.48 |
Other IHD | 11,258 (37.7) | 2,011 (36.6) | 9,247 (38.0) | 0.053 |
Ischemic stroke | 2,634 (8.8) | 552 (10.0) | 2,082 (8.5) | 0.0004 |
TIA/other CVA | 2,324 (7.8) | 395 (7.2) | 1,929 (7.9) | 0.07 |
PVD | 164 (0.5) | 38 (0.7) | 126 (0.5) | 0.12 |
Impact of diabetes on incidence of subsequent cardiovascular events
Subsequent CV Event Type* | Patients with Diabetes†‡ (n = 5,501) | Patients without Diabetes†‡ (n = 24,362) | P-value (χ2 test) |
---|---|---|---|
CABG | 147 (2.7) | 425 (1.7) | < 0.001 |
Other CV procedure | 391 (7.1) | 1,395 (5.7) | < 0.001 |
Myocardial infarction | 129 (2.3) | 375 (1.5) | < 0.001 |
Heart failure | 197 (3.6) | 425 (1.7) | < 0.001 |
Angina | 23 (0.4) | 83 (0.3) | 0.38 |
Other IHD | 613 (11.1) | 2,454 (10.1) | 0.02 |
Ischemic stroke | 105 (1.9) | 300 (1.2) | < 0.001 |
TIA/other CVA | 76 (1.4) | 212 (0.9) | < 0.001 |
PVD | 29 (0.5) | 80 (0.3) | 0.03 |
Impact of diabetes on health-care costs
Index CV Event Type* | Patients with Diabetes† (n = 5,501) | Patients without Diabetes† (n = 24,362) | ||||
---|---|---|---|---|---|---|
No. of Patients
|
Cost of Hospitalization
‡
|
Hospital LOS
§
|
No. of Patients
|
Cost of Hospitalization
‡
|
Hospital LOS
§
| |
All CV event types** | 5,501 | 17,435 (21,613) | 4.8 (3.5) | 24,362 | 16,917 (20,342) | 4.3 (3.0) |
CABG | 412 | 60,385 (38,622) | 10.0 (3.9) | 1,492 | 55,004 (32,109) | 9.0 (3.6) |
Other CV procedure | 1,417 | 25,925 (19,369) | 4.1 (2.4) | 7,196 | 26,331 (21,446) | 4.1 (2.4) |
Myocardial infarction | 1,420 | 26,035 (27,918) | 5.2 (3.6) | 7,811 | 24,802 (24,278) | 4.6 (2.9) |
Heart failure | 686 | 11,178 (13,168) | 5.7 (3.7) | 1,558 | 12,560 (16,245) | 5.6 (3.6) |
Angina | 315 | 7,038 (6,975) | 2.9 (1.4) | 1,336 | 6,878 (7,722) | 2.7 (1.4) |
Other IHD | 2,011 | 17,869 (20,538) | 4.2 (3.0) | 9,247 | 14,740 (17,549) | 3.7 (2.6) |
Ischemic stroke | 552 | 11,802 (12,025) | 5.6 (3.7) | 2,082 | 12,667 (13,344) | 5.4 (3.3) |
TIA/other CVA | 395 | 6,638 (6,733) | 4.0 (3.4) | 1,929 | 6,711 (6,379) | 3.7 (2.7) |
PVD | 38 | 19,432 (25,386) | 8.1 (6.4) | 126 | 15,315 (17,835) | 6.6 (5.0) |
First Recurrent CV Event Type* | Patients with Diabetes† (n = 5,501) | Patients without Diabetes† (n = 24,362) | ||||
---|---|---|---|---|---|---|
No. of Patients
|
Cost of Hospitalization
‡
|
Hospital LOS
§
|
No. of Patients
|
Cost of Hospitalization
‡
|
Hospital LOS
§
| |
All CV event types** | 1,071 | 18,488 (22,014) | 5.6 (12.6) | 3,734 | 17,481 (22,895) | 4.6 (7.3) |
CABG | 112 | 43,404 (28,686) | 10.8 (33.6) | 338 | 47,110 (39,612) | 8.3 (7.1) |
Other CV procedure | 346 | 19,831 (14,867) | 3.2 (2.3) | 1,281 | 18,807 (15,588) | 2.9 (2.6) |
Myocardial infarction | 106 | 22,854 (33,721) | 8.2 (34.8) | 332 | 22,125 (27,934) | 5.1 (5.0) |
Heart failure | 168 | 14,031 (21,581) | 7.5 (6.9) | 363 | 14,398 (26,197) | 5.7 (5.4) |
Angina | 18 | 8,016 (9,243) | 3.9 (4.0) | 72 | 8,477 (9,039) | 3.2 (2.3) |
Other IHD | 554 | 21,445 (21,768) | 4.3 (5.5) | 2,316 | 18,038 (19,859) | 3.6 (3.2) |
Ischemic stroke | 96 | 11,168 (8,687) | 5.0 (4.0) | 267 | 10,804 (10,594) | 6.0 (8.3) |
TIA/other CVA | 64 | 7,501 (6,720) | 10.0 (14.1) | 179 | 9,195 (11,887) | 12.8 (24.6) |
PVD | 25 | 23,146 (23,278) | 7.6 (5.3) | 61 | 14,788 (13,850) | 4.9 (4.4) |
Follow-up CV Event Type* | Patients with Diabetes† (n = 5,501) | Patients without Diabetes† (n = 24,362) | ||||
---|---|---|---|---|---|---|
No. of Patients
|
Cost of
Follow-Up
‡
|
Hospital LOS
§
|
No. of Patients
|
Cost of
Follow-Up
‡
|
Hospital LOS
§
| |
1 Year: | ||||||
All patients with CV events** | 5,501 | 8,805 (22,277) | 1.6 (7.4) | 24,362 | 6,982 (18,545) | 1.0 (4.8) |
CABG | 412 | 6,894 (13,122) | 0.7 (2.8) | 1,492 | 6,690 (13,159) | 0.6 (2.8) |
Other CV procedure | 1,417 | 11,195 (19,917) | 1.3 (3.7) | 7,196 | 9,628 (22,946) | 0.9 (3.5) |
Myocardial infarction | 1,420 | 12,256 (31,941) | 1.7 (5.2) | 7,811 | 9,502 (24,244) | 1.1 (4.4) |
Heart failure | 686 | 9,324 (22,806) | 3.3 (16.4) | 1,558 | 8,711 (26,334) | 1.9 (6.4) |
Angina | 315 | 5,463 (19,684) | 0.6 (3.1) | 1,336 | 3,985 (11,352) | 0.4 (1.6) |
Other IHD | 2,011 | 8,053 (17,264) | 1.2 (4.4) | 9,247 | 6,167 (14,279) | 0.8 (3.4) |
Ischemic stroke | 552 | 7,521 (13,388) | 2.2 (7.0) | 2,082 | 6,052 (11,827) | 1.9 (9.4) |
TIA/other CVA | 395 | 3,648 (8,469) | 0.9 (3.6) | 1,929 | 2,544 (9,369) | 0.6 (5.3) |
PVD | 38 | 8,537 (20,215) | 2.5 (5.0) | 126 | 6,163 (17,706) | 0.9 (3.2) |
2 Years: | ||||||
All patients with CV events†† | 2,132 | 13,860 (26,619) | 2.3 (8.6) | 9,522 | 10,056 (22,677) | 1.3 (5.3) |
CABG | 155 | 10,161 (14,314) | 2.3 (19.6) | 589 | 10,313 (17,319) | 0.9 (3.8) |
Other CV procedure | 560 | 17,980 (29,350) | 2.5 (11.5) | 2,806 | 13,980 (24,577) | 1.2 (3.8) |
Myocardial infarction | 530 | 19,703 (37,992) | 2.9 (12.1) | 3,091 | 13,520 (27,764) | 1.4 (5.1) |
Heart failure | 251 | 14,535 (27,065) | 4.1 (11.6) | 568 | 12,606 (35,669) | 2.6 (8.2) |
Angina | 129 | 6,869 (13,410) | 1.2 (4.0) | 576 | 5,015 (11,391) | 0.4 (1.7) |
Other IHD | 802 | 12,485 (20,869) | 1.6 (4.4) | 3,585 | 9,207 (18,789) | 1.1 (3.8) |
Ischemic stroke | 211 | 12,893 (19,845) | 3.4 (9.5) | 694 | 8,686 (15,325) | 1.9 (8.2) |
TIA/other CVA | 155 | 6,916 (14,687) | 1.5 (7.3) | 844 | 4,576 (15,012) | 1.0 (7.8) |
PVD | 14 | 9,802 (14,433) | 1.1 (3.3) | 52 | 5,380 (10,697) | 0.7 (2.0) |
3 Years: | ||||||
All patients with CV events‡‡ | 735 | 16,149 (27,290) | 3.3 (12.4) | 3,141 | 12,163 (26,268) | 1.8 (5.8) |
CABG | 54 | 14,299 (20,342) | 5.6 (34.4) | 189 | 11,445 (17,920) | 1.1 (3.9) |
Other CV procedure | 174 | 21,821 (29,208) | 4.2 (19.7) | 864 | 17,150 (24,413) | 1.5 (3.7) |
Myocardial infarction | 194 | 19,773 (32,653) | 4.0 (18.9) | 984 | 16,566 (33,829) | 2.0 (6.0) |
Heart failure | 84 | 17,641 (33,665) | 6.2 (17.5) | 198 | 15,309 (40,834) | 2.9 (7.0) |
Angina | 45 | 10,744 (19,220) | 1.9 (6.6) | 185 | 4,844 (9,124) | 0.5 (1.5) |
Other IHD | 268 | 16,428 (25,001) | 2.7 (5.8) | 1,179 | 12,031 (21,739) | 1.9 (6.3) |
Ischemic stroke | 71 | 13,654 (19,163) | 3.3 (8.9) | 242 | 8,526 (14,211) | 1.8 (6.0) |
TIA/other CVA | 62 | 9,045 (21,836) | 1.4 (4.2) | 284 | 4,400 (10,622) | 0.8 (3.8) |
PVD | 2 | 10,119 (10,258) | 0.0 (0.0) | 22 | 6,678 (14,186) | 1.2 (2.6) |